Busulfan/Melphalan/Antithymocyte Globulin Followed by Unrelated Donor Cord Blood Transplantation for Treatment of Infant Leukemia and Leukemia in Young Children: The Cord Blood Transplantation Study (COBLT) Experience
Tài liệu tham khảo
Grewal, 2003, Unrelated donor hematopoietic cell transplantation, Blood, 101, 4233, 10.1182/blood-2002-08-2510
Confer, 1997, Unrelated marrow donor registries, Curr Opin Hematol, 4, 408, 10.1097/00062752-199704060-00008
Davies, 1997, Unrelated donor bone marrow transplantation for children with acute leukemia, J Clin Oncol, 15, 557, 10.1200/JCO.1997.15.2.557
Bunin, 2002, Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission, Blood, 99, 3151, 10.1182/blood.V99.9.3151
Wagner, 1996, Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors, Blood, 88, 795, 10.1182/blood.V88.3.795.795
Rubinstein, 1998, Outcomes among 562 recipients of placental-blood transplants from unrelated donors, N Engl J Med, 339, 1565, 10.1056/NEJM199811263392201
Kurtzberg, 1996, Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients, N Engl J Med, 335, 157, 10.1056/NEJM199607183350303
Gluckman, 1997, Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group, N Engl J Med, 337, 373, 10.1056/NEJM199708073370602
Davies, 2000, Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia, J Clin Oncol, 18, 340, 10.1200/JCO.2000.18.2.340
Ringden, 1996, Br J Haematol, 93, 637, 10.1046/j.1365-2141.1996.d01-1681.x
Bunin, 2003, Randomized trial of busulfan vs. total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia, Bone Marrow Transplant, 32, 543, 10.1038/sj.bmt.1704198
Fraser, 1998, Cord Blood Transplantation Study (COBLT), J Hematother, 7, 521, 10.1089/scd.1.1998.7.521
Rubinstein, 1995, Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution, Proc Natl Acad Sci U S A, 92, 10119, 10.1073/pnas.92.22.10119
Przepiorka, 1995, 1994 Consensus Conference on Acute GVHD Grading, Bone Marrow Transplant, 15, 825
Weisdorf, 2003, Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation, Biol Blood Marrow Transplant, 9, 512, 10.1016/S1083-8791(03)00162-9
Bearman, 1988, Regimen-related toxicity in patients undergoing bone marrow transplantation, J Clin Oncol, 6, 1562, 10.1200/JCO.1988.6.10.1562
Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452
Gooley, 1999, Estimation of failure probabilities in the presence of competing risks, Stat Med, 18, 695, 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
Sanders, 2005, Final adult height of patients who received hematopoietic cell transplantation in childhood, Blood, 105, 1348, 10.1182/blood-2004-07-2528
Sanders, 2005, Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia, Blood, 105, 3749, 10.1182/blood-2004-08-3312
Matsuyama, 1998, Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen, Bone Marrow Transplant, 22, 21, 10.1038/sj.bmt.1701276
Vey, 1996, A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignancies, Bone Marrow Transplant, 18, 495
Diaz, 1999, High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors, Bone Marrow Transplant, 24, 1157, 10.1038/sj.bmt.1702042
Matsuyama, 2000, Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission, Eur J Cancer, 36, 368, 10.1016/S0959-8049(99)00329-9
Cornetta, 2005, Umbilical cord blood transplantation in adults, Biol Blood Marrow Transplant, 11, 149, 10.1016/j.bbmt.2004.11.020
Bornhauser, 2003, Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells, Blood, 102, 820, 10.1182/blood-2002-11-3567
Slattery, 1995, Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics, Bone Marrow Transplant, 16, 31
Bleyzac, 2001, Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens, Bone Marrow Transplant, 28, 743, 10.1038/sj.bmt.1703207
Barker, 2003, Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning, Blood, 102, 1915, 10.1182/blood-2002-11-3337
Chan, 1999, Fludarabine-based preparative protocol for unrelated donor cord blood transplantation in children, Bone Marrow Transplant, 23, 849, 10.1038/sj.bmt.1701657
Rubinstein, 2001, HLA matching for bone marrow transplantation—how much is enough?, N Engl J Med, 345, 1842, 10.1056/NEJM200112203452511
Rubinstein, 1999, The Placental/Umbilical Cord Blood Program of the New York Blood Center. A progress report, Ann N Y Acad Sci, 872, 328, 10.1111/j.1749-6632.1999.tb08477.x